Anzeige
Mehr »
Login
Sonntag, 06.10.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Achtung Vervielfachung! URAN-AKTIEN starten durch …. Jetzt kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 03.05.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
03.05.Instalco AB: Interim report January - March 202454Stable development for continued longevityJanuary - March 2024Net sales increased by 0.6 percent and amounted to SEK 3,283 (3,264) million. Organic development, adjusted for currency effects, amounted...
► Artikel lesen
03.05.Egetis Therapeutics AB: Interim report Q1 202491Egetis accelerates pre-launch activities for Emcitate® (tiratricol) in the EUSeveral pre-launch activities have commenced to increase disease awareness of MCT8 deficiency and its impact on patients...
► Artikel lesen
03.05.CapMan Oyj: CapMan Plc 1-3 2024 Interim Report50CapMan Plc Stock Exchange Release / Q1 Interim Report 3 May 2024 at 8:00 a.m. EEST CapMan Plc 1-3 2024 Interim Report Results and significant events in 1-3 2024: Assets under management...
► Artikel lesen
03.05.Moment Group AB: Interim report January-March 202454Positive operating earnings in the first quarter FIRST QUARTER 2024 2024 2023 2023 SEK million Jan-Mar Jan-Mar Jan-Dec Net...
► Artikel lesen
03.05.Scandi Standard AB: Scandi Standard AB (publ) interim report January - March 202456Significant volume and profit growth January - March 2024 Chicken processed (grill weight) amounted to 70 (65) thousand tonne which corresponds to an 8 per cent increase. Net sales amounted...
► Artikel lesen
03.05.Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2024: Profitability continued to improve, operating cash flow was strong63Pihlajalinna Plc Interim Report 3 May 2024 at 8:00 Pihlajalinna Interim Report 1 January-31 March 2024 Profitability continued to improve, operating...
► Artikel lesen
03.05.Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2024: Profitability continued to improve, operating cash flow was strong18Pihlajalinna Plc Interim Report 3 May 2024 at 8:00 Pihlajalinna Interim Report 1 January-31 March 2024 Profitability continued to improve, operating...
► Artikel lesen
03.05.KlaraBo Sverige AB: Interim report 1 January - 31 March 202453Revenue for the quarter amounted to SEK 156.7 million (142.9), a year-on-year increase of 10 per cent. Net operating income amounted to SEK 73.4 million (67.4), up 9 per cent year-on-year. Income...
► Artikel lesen
03.05.Castellum AB: Interim Report January-March 202459"In the wake of the struggle against inflation, we are seeing a more hesitant rental market. However, Castellum's net leasing was positive during the quarter, income from property management increased...
► Artikel lesen
03.05.Fastighets AB Balder: Fastighets AB Balder's (publ) Interim report January-March 202451Profit from property management attributable to the parent company's shareholders amounted to SEK 1,402m (1,549), corresponding to a decrease per share by 10% to SEK 1.21 (1.34). Long term net...
► Artikel lesen
03.05.Logistea AB: Logistea publishes Interim Report for Q1 202445Continued expansion based on a strong positionSummary for the quarter January - March 2024· Income increased by 17 per cent and amounted to SEK 111 million (95).· Net operating income increased by 18...
► Artikel lesen
03.05.China Nonferrous Gold Limited: Financial Position Update84LONDON--(BUSINESS WIRE)-- China Nonferrous Gold Limited ("CNG" or the "Company") Financial Position Update China Nonferrous Gold Limite (AIM: CNG), the mineral exploration...
► Artikel lesen
03.05.Gold Reserve Announces Appointment of Executive Vice-Chairman; Amendment to Equity Incentive Plan58SPOKANE, Wash.--(BUSINESS WIRE)--Gold Reserve Inc. (TSX.V: GRZ) (OTCQX: GDRZF) ("Gold Reserve" or the "Company") today announces the appointment of Paul Rivett as a director and as the Executive...
► Artikel lesen
03.05.Ault Alliance Completes Final Distribution of TurnOnGreen Securities89LAS VEGAS--(BUSINESS WIRE)--Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company, ("Ault Alliance" or the "Company"), hereby announces that it has completed the final distribution...
► Artikel lesen
03.05.BME heisst Puig an der Börse in Barcelona willkommen222Es ist der grösste Börsengang in Spanien seit 2015 und der grösste weltweit in diesem Jahr. Das mit 13,9 Milliarden Euro bewertete Unternehmen debütiert an der Börse mit einem Preis von 24,50 Euro pro...
► Artikel lesen
03.05.Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K118IRVINE, Calif.--(BUSINESS WIRE)--Priveterra Acquisition Corp. II (NASDAQ: PMGMU, PMGM, PMGMW) (the "Company") today announced that on April 29, 2024, the Company received a notice (the "10-K Notice")...
► Artikel lesen
03.05.Quantum Corporation Provides Updated Plan to Nasdaq200SAN JOSE, Calif.--(BUSINESS WIRE)--Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"), a leader in solutions for AI and unstructured data, today provided an update related to the Company's...
► Artikel lesen
03.05.Ferrovial Completes Regulatory Review Process for Nasdaq Listing236Listing marks intent to expand already-robust presence in North America AMSTERDAM, May 3, 2024 /PRNewswire/ -- Ferrovial SE ("Ferrovial" or the "Company"), one of the world's leading infrastructure...
► Artikel lesen
03.05.Delcath Systems, Inc.: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)344NEW YORK, May 3, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers...
► Artikel lesen
03.05.Sentynl Therapeutics Announces Global Acquisition of Zokinvy (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals315Sentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseasesZokinvy is approved in the U.S. (2020), European...
► Artikel lesen
Seite:  Weiter >>